Cargando…
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
BACKGROUND: The overall prognosis of non-small cell lung cancer (NSCLC) is poor, and currently only patients with localized disease are potentially curable. Therefore, preferably non-invasively determined biomarkers that detect NSCLC patients at early stages of the disease are of high clinical relev...
Autores principales: | Djureinovic, Dijana, Pontén, Victor, Landelius, Per, Al Sayegh, Sahar, Kappert, Kai, Kamali-Moghaddam, Masood, Micke, Patrick, Ståhle, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664554/ https://www.ncbi.nlm.nih.gov/pubmed/31357969 http://dx.doi.org/10.1186/s12885-019-5943-3 |
Ejemplares similares
-
Plasma Protein Profiling Reveal Osteoprotegerin as a Marker of Prognostic Impact for Colorectal Cancer
por: Birgisson, Helgi, et al.
Publicado: (2018) -
Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma
por: Su, David, et al.
Publicado: (2023) -
Agonistic CD40 Antibodies in Cancer Treatment
por: Djureinovic, Dijana, et al.
Publicado: (2021) -
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
por: Gremel, Gabriela, et al.
Publicado: (2017) -
Depression, GABA, and Age Correlate with Plasma Levels of Inflammatory Markers
por: Bhandage, Amol K., et al.
Publicado: (2019)